gland pharma glp-1 capacity expansion reported a strong December quarter with 22.5% revenue growth and 27% YoY profit growth, driven by healthy performance across the US, India, and Europe. The stock reacted positively, gaining over Collection_Nausea Relief Flavor:Pomegranate Berry China Challenges GLP-1 Leaders

gland pharma glp-1 capacity expansion reported a strong December quarter with 22.5% revenue growth and 27% YoY profit growth, driven by healthy performance across the US, India, and Europe. The stock reacted positively, gaining over Collection_Nausea Relief Flavor:Pomegranate Berry China Challenges GLP-1 Leaders

China Challenges GLP-1 Leaders ㅤ Kailera licensed a portfolio of obesity therapies from China's Jiangsu Hengrui, including a Phase 3 GLP-1 candidate that delivered up to 10.9% average weight loss at 44

Hanlon P, Butterly E, Wei L, Wightman H, Almazam SA, Alsallumi K, et al

Collection_Nausea Relief

Flavor:Pomegranate Berry

247 The primary action often occurs through indirect mechanisms, such as insulin and somatostatin